ACAD ACADIA Pharmaceuticals Inc. - Common Stock
$30,66
Prezzo · Ago 19, 2026
Fondamentali al Ago 5, 2026
Intervallo 52 sett.
$20–$31
98% of range
Rating Analisti
BUY
27 analysts
Prezzo Obiettivo
$34
+10% upside
P/E (TTM)
13.3
ROE
38.1%
Margine di Profitto Netto
36.5%
Informazioni su ACADIA Pharmaceuticals Inc. - Common Stock Panoramica della società da Wikipedia
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Leggi di più
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Product development
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brain’s serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Nuplazid is the trade name for Acadia's proprietary molecule, pimavanserin, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis, major depressive disorder, schizophrenia inadequate response, and schizophrenia negative symptoms.
As of 1997, Acadia was among several companies that licensed compounds from Genzyme's small-molecule compound library.
In 2023, the FDA approved trofinetide (marketed as Daybue) for use in Rett syndrome.
History
Acadia started in 1993 as Receptor Technologies, based in Winooski, Vermont. In 1997, the company relocated all operations and management from Vermont to San Diego, California, as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk Kapitalanlæg Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
The company planned to conduct an initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. At the time, Acadia and Allergan were collaborating on development of a treatment for glaucoma, and Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only US$35 million. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised US$102 million.
In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
Corporate governance
In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
== References ==
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
ACAD Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$30.66
Capitalizzazione di Mercato
$5.22B
P/E (TTM)
13.3
EPS (TTM)
$2.30
Ricavi (TTM)
$1.07B
Rendimento div.
—
ROE
38.1%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$20 – $31
ACAD Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$1.07B
2016-12-31
→
2025-12-31
EPS
$2.30
2020-12-31
→
2025-12-31
Flusso di cassa libero
$105M
2016-12-31
→
2025-12-31
Margini
36.5%
2016-12-31
→
2023-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
ACAD
Mediana dei peer
P/E (TTM)
13.3
13.2
P/S (TTM)
4.9
55.3
P/B
4.3
3.5
Price / FCF (Prezzo / FCF)
49.7
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
ACAD
Mediana dei peer
Operating Margin (Margine Operativo)
9.8%
—
Net Profit Margin (Margine di Profitto Netto)
36.5%
-151.2%
ROA
28.4%
-42.2%
ROE
38.1%
-52.8%
ROIC
24.0%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
ACAD
Mediana dei peer
Current Ratio (Rapporto corrente)
3.8
10.3
Quick Ratio
1.1
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
ACAD
Mediana dei peer
Revenue YoY (Ricavi YoY)
11.9%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
27.5%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
19.4%
—
EPS YoY
69.1%
—
Net Income YoY (Utile Netto YoY)
72.7%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
ACAD
Mediana dei peer
ACAD Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
27 analisti
- Acquisto forte 7 25,9%
- Compra 14 51,9%
- Mantieni 5 18,5%
- Vendi 1 3,7%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
20 analisti · 2026-08-18
Mediana
$36.00
Ora
$30.66
Basso
$17.00
Alto
$49.00
Target mediano
$36.00
+17,4%
Target medio
$33.85
+10,4%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.30%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $0.18 | $0.06 | 0.12% |
| 31 Marzo 2026 | $0.02 | $0.06 | -0.04% |
| 31 Dicembre 2025 | $1.60 | $0.14 | 1.5% |
| 30 Settembre 2025 | $0.42 | $0.15 | 0.27% |
| 30 Giugno 2025 | $0.16 | $0.14 | 0.02% |
| 31 Marzo 2025 | $0.11 | $0.11 | -0.00% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| PBLS | — | — | — | — | — | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Cost of Revenue | $89M | $82M | $42M | $10M | $19M | $10M | $11M | $12M | $9M | $3M | · | · | |
| Gross Profit | · | · | $685M | $507M | $473M | $432M | $328M | $211M | $116M | $14M | · | · | |
| R&D Expense | $329M | $303M | $352M | $362M | $239M | $319M | $240M | $187M | $149M | $99M | $74M | $61M | |
| SG&A Expense | $549M | $488M | $407M | $369M | $396M | $389M | $326M | $266M | $255M | $186M | $88M | $33M | |
| Operating Expenses | $967M | $727M | $800M | $741M | $655M | $728M | $586M | $471M | $417M | $290M | $165M | $93M | |
| Operating Income | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M | |
| Other Non-op | $2M | $2M | $5M | $4M | $2M | $-997.0K | $997.0K | $-2M | · | · | · | · | |
| Pretax Income | $139M | $258M | $-51M | $-213M | $-168M | $-281M | $-234M | $-244M | $-288M | $-270M | $-164M | $-92M | |
| Income Tax | $-252M | $32M | $10M | $3M | $351.0K | $611.0K | $876.0K | $1M | $1M | $1M | $330.0K | $0 | |
| Net Income | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| EPS (Basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| Shares (Basic) | 168,356,000 | 165,717,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| Shares (Diluted) | 169,919,000 | 166,362,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| EBITDA | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M |
Stato Patrimoniale 25
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $178M | $320M | $189M | $115M | $147M | $326M | $190M | $135M | $69M | $164M | $102M | $62M | |
| Receivables | $121M | $99M | $98M | $62M | $64M | $48M | $36M | $26M | $17M | $6M | · | · | |
| Inventory | $111M | $92M | $40M | $12M | $14M | $10M | $6M | $4M | $5M | $4M | · | · | |
| Prepaid Expense | $60M | $56M | $39M | $21M | $24M | $26M | $19M | $21M | $8M | $8M | $2M | $1M | |
| Current Assets | $1.06B | $938M | $616M | $508M | $618M | $718M | $760M | $526M | $373M | $548M | $219M | $325M | |
| PP&E (Net) | $8M | $4M | $5M | $6M | $8M | $9M | $3M | $3M | $3M | $3M | $2M | $553.0K | |
| PP&E (Gross) | $17M | $14M | $14M | $14M | $14M | $13M | $9M | $8M | $7M | $6M | $5M | $3M | |
| Accum. Depreciation | $9M | $10M | $10M | $8M | $6M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $109M | $120M | $65M | $0 | $0 | $1M | $3M | $4M | $6M | $7M | · | · | |
| Other Non-current Assets | $4M | $359.0K | $476.0K | $8M | $4M | $2M | $3M | $2M | $354.0K | $785.0K | $329.0K | $287.0K | |
| Total Assets | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Accounts Payable | $11M | $16M | $18M | $13M | $7M | $8M | $7M | $3M | $9M | $4M | $2M | $2M | |
| Accrued Liabilities | $266M | $379M | $237M | $113M | $89M | $97M | $68M | $56M | $40M | $36M | $20M | $14M | |
| Current Liabilities | $277M | $395M | $254M | $126M | $96M | $106M | $75M | $60M | $49M | $43M | $22M | $16M | |
| Capital Leases | $41M | $42M | $48M | $53M | $56M | $44M | $6M | · | · | · | · | · | |
| Deferred Tax | $11M | $11M | $12M | $13M | $14M | $13M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $19M | $18M | $15M | $9M | $7M | $5M | $3M | $2M | · | · | · | · | |
| Total Liabilities | $337M | $455M | $317M | $187M | $159M | $156M | $84M | $61M | $49M | $43M | $22M | $16M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | $14.0K | $12.0K | $12.0K | $10.0K | $10.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $1.45B | $862M | $808M | |
| Retained Earnings | $-1.81B | $-2.20B | $-2.43B | $-2.37B | $-2.15B | $-1.99B | $-1.70B | $-1.47B | $-1.22B | $-934M | $-663M | $-498M | |
| AOCI | $1M | $292.0K | $24.0K | $-975.0K | $-192.0K | $36.0K | $297.0K | $-372.0K | $-399.0K | $106.0K | $11.0K | $-9.0K | |
| Stockholders' Equity | $1.23B | $733M | $432M | $400M | $541M | $627M | $699M | $479M | $335M | $518M | $200M | $309M | |
| Liabilities + Equity | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Shares Outstanding | 170,309,376 | 166,708,856 | 164,650,219 | 162,064,872 | 161,012,695 | 159,637,771 | 155,275,300 | 143,853,597 | 124,410,552 | 121,367,169 | 101,938,702 | 100,047,331 |
Flusso di cassa 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $206.0K | |
| Stock-based Comp | $52M | $67M | $66M | $68M | $64M | $84M | $82M | $82M | $76M | $55M | $40M | $16M | |
| Deferred Tax | $-250M | $0 | $0 | $3M | $351.0K | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $11M | $15M | $4M | $0 | $1M | $1M | $1M | $1M | $1M | $985.0K | $0 | $0 | |
| Operating Cash Flow | $110M | $158M | $17M | $-114M | $-126M | $-136M | $-151M | $-167M | $-218M | $-208M | $-122M | $-66M | |
| CapEx | $5M | $523.0K | $50.0K | $0 | $1M | $8M | $1M | $2M | $812.0K | $2M | $2M | $180.0K | |
| Investing Cash Flow | $-303M | $-31M | $32M | $73M | $-71M | $193M | $-166M | $-71M | $92M | $-262M | · | · | |
| Stock Issued | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Net Stock Activity | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Financing Cash Flow | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $534M | · | · | |
| Net Change in Cash | $-143M | $134M | $74M | $-33M | $-179M | $137M | $55M | $68M | $-94M | $63M | $40M | $50M | |
| Taxes Paid | $25M | $20M | $6M | $2M | $1M | $1M | $2M | $1M | $1M | $-365.0K | $415.0K | · | |
| Free Cash Flow | $105M | $157M | $17M | $-114M | $-127M | $-144M | $-152M | $-170M | $-219M | $-212M | $-124M | $-67M |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | · | · | |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -77062.5% | |
| Pretax Margin | 13.0% | 26.9% | -7.0% | -41.3% | -34.6% | -63.6% | -69.1% | -109.0% | -230.8% | -1558.2% | -269037.7% | · | |
| EBITDA Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| ROA | 28.4% | 23.4% | -9.2% | -33.5% | -22.6% | -36.0% | -35.5% | -53.0% | -61.2% | -69.3% | -60.1% | -35.9% | |
| ROE | 38.1% | 34.6% | -15.4% | -52.3% | -30.3% | -43.9% | -33.9% | -69.8% | -67.8% | -75.6% | -64.6% | -37.6% | |
| ROIC | 24.0% | 27.6% | -20.4% | -56.5% | -31.6% | -45.8% | -35.4% | -51.9% | -87.5% | -52.9% | -82.6% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 | 3.5 | 3.0 | 2.7 | 1.8 | 4.0 | 4.7 | 3.9 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.9 | 1.2 | 1.6 | 0.8 | 0.9 | 1.3 | 2.2 | · | 1.9 | 1.5 | · | · | |
| Receivables Turnover | 9.7 | 9.7 | 9.1 | 8.2 | 8.6 | 10.5 | 11.0 | 10.3 | 10.7 | 5.9 | · | · |
Tassi di Crescita 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.9% | 31.9% | 40.5% | 6.8% | 9.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 25.5% | 18.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 69.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 72.7% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Net Income TTM | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| Market Cap | $4.55B | $3.06B | $5.16B | $2.58B | $3.76B | $8.53B | $6.64B | $2.33B | $3.75B | $3.50B | $3.63B | $3.18B | |
| P/E | 11.6 | 13.5 | -84.6 | -11.9 | -22.2 | -29.9 | · | · | · | · | · | · | |
| P/S | 4.2 | 3.2 | 7.1 | 5.0 | 7.8 | 19.3 | 19.6 | 10.4 | 30.0 | 202.0 | 59575.7 | 26470.9 | |
| P/B | 3.7 | 4.2 | 11.9 | 6.4 | 6.9 | 13.6 | 9.5 | 4.9 | 11.2 | 6.8 | 18.2 | 10.3 | |
| P / Tangible Book | 4.1 | 5.0 | 14.1 | 6.4 | 6.9 | 13.6 | · | · | · | · | · | · | |
| P / Cash Flow | 41.4 | 19.4 | 308.7 | -22.6 | -29.9 | -62.7 | -44.0 | -13.9 | -17.2 | -16.6 | -29.8 | -47.8 | |
| P / FCF | 43.3 | 19.5 | 309.6 | -22.6 | -29.6 | -59.4 | -43.6 | -13.7 | -17.1 | -16.5 | -29.3 | -47.7 | |
| Earnings Yield | 8.6% | 7.4% | -1.2% | -8.4% | -4.5% | -3.4% | · | · | · | · | · | · |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $268M | $284M | $279M | $265M | $244M | $260M | $250M | $242M | $206M | $231M | $212M | $165M | $118M | $136M | $131M | |
| Cost of Revenue | $28M | $25M | $26M | $22M | $21M | $20M | $22M | $19M | $18M | $23M | $18M | $15M | $7M | $2M | $2M | $2M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $213M | $197M | $158M | $117M | $134M | $129M | |
| R&D Expense | $82M | $77M | $85M | $88M | $78M | $78M | $101M | $67M | $76M | $60M | $67M | $157M | $59M | $69M | $76M | $81M | |
| SG&A Expense | $160M | $171M | $156M | $133M | $134M | $126M | $130M | $133M | $117M | $108M | $111M | $98M | $96M | $101M | $104M | $78M | |
| Operating Expenses | $270M | $273M | $267M | $243M | $232M | $225M | $106M | $219M | $212M | $191M | $196M | $269M | $162M | $172M | $183M | $162M | |
| Operating Income | $38M | $-5M | $17M | $36M | $32M | $19M | $154M | $32M | $30M | $15M | $35M | $-58M | $3M | $-54M | $-46M | $-31M | |
| Other Non-op | $647.0K | $542.0K | $596.0K | $593.0K | $594.0K | $588.0K | $575.0K | $576.0K | $386.0K | $286.0K | $0 | $2M | $-1M | $5M | $2M | $2M | |
| Pretax Income | $46M | $4M | $26M | $45M | $40M | $28M | $161M | $39M | $37M | $21M | $40M | $-52M | $6M | $-45M | $-41M | $-26M | |
| Income Tax | $15M | $344.0K | $-247M | $-27M | $14M | $9M | $17M | $6M | $4M | $4M | $-6M | $13M | $5M | $-2M | $835.0K | $768.0K | |
| Net Income | $32M | $4M | $274M | $72M | $27M | $19M | $144M | $33M | $33M | $17M | $46M | $-65M | $1M | $-43M | $-42M | $-27M | |
| EPS (Basic) | $0.18 | $0.02 | $1.62 | $0.43 | $0.16 | $0.11 | $0.87 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| EPS (Diluted) | $0.18 | $0.02 | $1.61 | $0.42 | $0.16 | $0.11 | $0.86 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| Shares (Basic) | 171,603,000 | 170,517,000 | -335,115,000 | 168,836,000 | 167,827,000 | 166,808,000 | -330,606,000 | 165,974,000 | 165,551,000 | 164,798,000 | -326,136,000 | 164,234,000 | 163,458,000 | 162,263,000 | 128,494 | 161,852 | |
| Shares (Diluted) | 172,851,000 | 172,706,000 | -337,080,000 | 170,650,000 | 168,681,000 | 167,668,000 | -332,613,000 | 166,178,000 | 166,174,000 | 166,623,000 | -327,724,000 | 164,234,000 | 165,046,000 | 162,263,000 | 128,494 | 161,852 | |
| EBITDA | $38M | $-5M | · | $36M | $32M | $19M | · | $32M | $30M | $15M | · | $-58M | $3M | $-54M | · | $-31M |
Stato Patrimoniale 24
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $385M | $282M | $178M | $258M | $254M | $218M | $320M | $155M | $177M | $205M | $189M | $98M | $108M | $291M | $115M | $155M | |
| Receivables | $151M | $135M | $121M | $116M | $108M | $106M | $99M | $98M | $104M | $95M | · | $93M | $82M | $66M | · | $56M | |
| Inventory | $109M | $112M | $111M | $106M | $111M | $103M | $92M | $87M | $86M | $67M | · | $25M | $14M | $11M | · | $12M | |
| Prepaid Expense | $69M | $65M | $60M | $61M | $53M | $53M | $56M | $52M | $46M | $43M | · | $38M | $24M | $24M | · | $23M | |
| Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $961M | $871M | $938M | $788M | $729M | $675M | · | $499M | $493M | $503M | · | $522M | |
| PP&E (Net) | $17M | $15M | $8M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $103M | $106M | $109M | $112M | $114M | $117M | $120M | $106M | $108M | $110M | · | $67M | $68M | $70M | · | · | |
| Other Non-current Assets | $4M | $4M | $4M | $3M | $2M | $1M | $359.0K | $359.0K | $476.0K | $476.0K | · | $475.0K | $11M | $12M | · | $6M | |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Accounts Payable | $45M | $12M | $11M | $22M | $20M | $18M | $16M | $19M | $20M | $19M | · | $12M | $19M | $17M | · | $10M | |
| Accrued Liabilities | $317M | $293M | $266M | $335M | $310M | $284M | $379M | $325M | $318M | $311M | · | $197M | $169M | $207M | · | $107M | |
| Current Liabilities | $361M | $306M | $277M | $357M | $330M | $303M | $395M | $344M | $338M | $331M | · | $210M | $188M | $224M | · | $117M | |
| Capital Leases | $60M | $39M | $41M | $43M | $45M | $45M | $42M | $40M | $47M | $49M | · | $48M | $50M | $51M | · | $54M | |
| Deferred Tax | · | · | $11M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $15M | $13M | $19M | $14M | $29M | $20M | $18M | $15M | $12M | $11M | · | $13M | $9M | $5M | · | $6M | |
| Total Liabilities | $436M | $357M | $337M | $413M | $403M | $367M | $455M | $400M | $397M | $391M | · | $270M | $247M | $281M | · | $177M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | $16.0K | $16.0K | $16.0K | · | $16.0K | |
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B | $-2.38B | $-2.41B | · | $-2.48B | $-2.41B | $-2.41B | · | $-2.33B | |
| AOCI | $-958.0K | $-563.0K | $1M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K | $-339.0K | $-229.0K | · | $-319.0K | $-535.0K | $-220.0K | · | $-1M | |
| Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917M | $822M | $765M | $733M | $577M | $517M | $464M | $432M | $362M | $396M | $374M | $400M | $426M | |
| Liabilities + Equity | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Shares Outstanding | 172,132,442 | 171,086,205 | 170,309,376 | 169,146,043 | 168,607,881 | 167,116,045 | 166,708,856 | 166,351,715 | 165,853,301 | 164,959,736 | · | 163,968,949 | 163,355,787 | 162,384,178 | · | 161,871,806 |
Flusso di cassa 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $15M | $13M | $13M | $14M | $11M | $10M | $26M | $16M | $15M | $18M | $19M | $15M | $15M | $14M | $18M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $2M | $2M | $5M | $1M | $1M | $1M | $0 | $0 | $0 | |
| Operating Cash Flow | $101M | $34M | $-49M | $74M | $64M | $20M | $40M | $63M | $25M | $29M | $85M | $-59M | $8M | $-18M | $-24M | $-727.0K | |
| CapEx | $5M | $5M | $4M | $388.0K | $297.0K | $0 | $453.0K | $70.0K | · | · | $0 | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-9M | $66M | $-56M | $-79M | $-43M | $-124M | $122M | $-82M | $-56M | $-14M | $-347.0K | $34M | $-194M | $193M | $-18M | $15M | |
| Stock Issued | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Stock Activity | · | $4M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Change in Cash | $103M | $105M | $-82M | $4M | $37M | $-102M | $164M | $-19M | $-28M | $16M | $90M | $-12M | $-181M | $176M | $-40M | $15M | |
| Free Cash Flow | · | $29M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| Net Margin | 10.2% | 1.4% | · | 25.8% | 10.1% | 7.8% | · | 13.1% | 13.8% | 8.0% | · | -30.8% | 0.67% | -36.3% | · | -20.8% | |
| Pretax Margin | 15.1% | 1.5% | · | 16.0% | 15.2% | 11.4% | · | 15.5% | 15.4% | 10.2% | · | -24.6% | 3.8% | -37.9% | · | -20.2% | |
| EBITDA Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| ROA | 2.1% | 0.27% | · | 6.2% | 2.5% | 1.9% | · | 4.1% | 4.3% | 2.2% | · | -10.5% | 0.18% | -6.7% | · | -4.1% | |
| ROE | 3.0% | 0.36% | · | 9.6% | 4.0% | 3.1% | · | 7.0% | 7.3% | 4.0% | · | -16.6% | 0.27% | -10.5% | · | -5.5% | |
| ROIC | 2.0% | -0.34% | · | 6.3% | 2.6% | 1.7% | · | 4.6% | 5.3% | 2.6% | · | -19.9% | 0.13% | -13.7% | · | -7.5% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.6 | · | 3.0 | 2.9 | 2.9 | · | 2.3 | 2.2 | 2.0 | · | 2.4 | 2.6 | 2.2 | · | 4.5 | |
| Quick Ratio | 1.5 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | 1.0 | 1.6 | · | 1.8 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.6 | · | 0.8 | 0.6 | 0.1 | · | 0.2 | |
| Receivables Turnover | 2.4 | 2.2 | · | 2.6 | 2.5 | 2.4 | · | 2.6 | 2.6 | 2.6 | · | 2.9 | 2.2 | 1.8 | · | 2.2 |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.12B | $1.06B | · | $1.04B | $1.00B | $943M | · | $929M | $891M | $814M | · | $632M | $551M | $520M | · | $512M | |
| Net Income TTM | $134M | $121M | · | $150M | $112M | $102M | · | $129M | $31M | $-2M | · | $-149M | $-111M | $-146M | · | $-217M | |
| Market Cap | $4.35B | $3.81B | · | $3.61B | $3.64B | $2.78B | · | $2.56B | $2.70B | $3.05B | · | $3.42B | $3.91B | $3.06B | · | $2.65B | |
| P/E | 32.4 | 31.4 | · | 24.0 | 32.2 | 27.2 | · | 19.7 | 90.3 | -1849.0 | · | -22.7 | -34.7 | -20.7 | · | -12.1 | |
| P/S | 3.9 | 3.6 | · | 3.5 | 3.6 | 2.9 | · | 2.8 | 3.0 | 3.7 | · | 5.4 | 7.1 | 5.9 | · | 5.2 | |
| P/B | 3.3 | 3.1 | · | 3.9 | 4.4 | 3.6 | · | 4.4 | 5.2 | 6.6 | · | 9.4 | 9.9 | 8.2 | · | 6.2 | |
| P / Tangible Book | 3.6 | 3.3 | · | 4.5 | 5.1 | 4.3 | · | 5.4 | 6.6 | 8.6 | · | 11.6 | 11.9 | 10.0 | · | 6.2 | |
| P / Cash Flow | · | 112.1 | · | · | · | 136.6 | · | · | · | 104.9 | · | · | · | -170.4 | · | · | |
| P / FCF | · | 132.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | · | 4.2% | 3.1% | 3.7% | · | 5.1% | 1.1% | -0.05% | · | -4.4% | -2.9% | -4.8% | · | -8.2% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $1.07B | $958M | $726M | $517M | $484M |
| Margine Lordo % | — | — | 94.3% | 98.0% | 97.8% |
| Margine Operativo % | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| Utile netto | $391M | $226M | $-61M | $-216M | $-168M |
| EPS Diluito | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $105M | $157M | $17M | $-114M | $-127M |
Ultime notizie Notizie recenti che menzionano questa società
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 388 filer · $3.3B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 56 (+10 vs trimestre precedente) | 37 (+10 vs trimestre precedente) | 136 (+11 vs trimestre precedente) | 100 (-13 vs trimestre precedente) | +17.3M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1.085.696.471 | 42.912.904 | 32,71% | Azioni |
| STATE STREET CORP | $229.628.164 | 9.076.212 | 6,92% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $223.612.785 | 8.838.450 | 6,74% | Azioni |
| RTW INVESTMENTS, LP | $180.756.457 | 7.144.524 | 5,45% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $145.822.875 | 5.763.750 | 4,39% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $88.971.384 | 3.516.656 | 2,68% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $73.088.127 | 2.888.204 | 2,20% | Azioni |
| Palo Alto Investors LP | $72.461.629 | 2.864.096 | 2,18% | Azioni |
| Qube Research & Technologies Ltd | $61.899.233 | 2.446.610 | 1,86% | Azioni |
| Point72 Asset Management, L.P. | $61.559.150 | 2.433.168 | 1,85% | Azioni |
| CITADEL ADVISORS LLC | $53.414.195 | 2.111.233 | 1,61% | Azioni |
| Pictet Asset Management Holding SA | $50.146.450 | 1.983.198 | 1,51% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $49.826.959 | 1.969.445 | 1,50% | Azioni |
| MARSHALL WACE, LLP | $44.649.289 | 1.764.794 | 1,35% | Azioni |
| BRAIDWELL LP | $41.653.895 | 1.646.399 | 1,25% | Azioni |
| NORGES BANK | $41.069.692 | 1.623.308 | 1,24% | Azioni |
| Frazier Life Sciences Management, L.P. | $36.386.409 | 1.438.198 | 1,10% | Azioni |
| Artisan Partners Limited Partnership | $33.525.890 | 1.325.134 | 1,01% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $32.449.679 | 1.282.596 | 0,98% | Azioni |
| GOLDMAN SACHS GROUP INC | $32.070.584 | 1.267.612 | 0,97% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.520.301 | 1.206.336 | 0,92% | Azioni |
| D. E. Shaw & Co., Inc. | $28.330.257 | 1.119.773 | 0,85% | Azioni |
| Allspring Global Investments Holdings, LLC | $26.143.513 | 1.037.441 | 0,79% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $23.452.898 | 926.992 | 0,71% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $23.082.961 | 912.370 | 0,70% | Azioni |
| BANK OF AMERICA CORP /DE/ | $21.702.062 | 857.789 | 0,65% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $17.985.922 | 710.906 | 0,54% | Azioni |
| Fisher Asset Management, LLC | $17.690.535 | 699.230 | 0,53% | Azioni |
| Allianz Asset Management GmbH | $15.730.341 | 706.664 | 0,47% | Azioni |
| RICE HALL JAMES & ASSOCIATES, LLC | $15.657.841 | 618.887 | 0,47% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $14.925.077 | 589.924 | 0,45% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $14.771.456 | 583.852 | 0,45% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12.903.000 | 510.000 | 0,39% | Azioni |
| Hudson Bay Capital Management LP | $11.764.500 | 465.000 | 0,35% | Azioni |
| GLENMEDE TRUST CO NA | $11.656.544 | 460.733 | 0,35% | Azioni |
| JUPITER ASSET MANAGEMENT LTD | $11.599.190 | 458.466 | 0,35% | Azioni |
| Public Sector Pension Investment Board | $11.014.988 | 435.375 | 0,33% | Azioni |
| MACKENZIE FINANCIAL CORP | $10.646.872 | 420.825 | 0,32% | Azioni |
| Ishara Investments LP | $10.373.000 | 410.000 | 0,31% | Azioni |
| TWO SIGMA ADVISERS, LP | $9.888.042 | 370.200 | 0,30% | Azioni |
| Balyasny Asset Management L.P. | $9.817.007 | 388.024 | 0,30% | Azioni |
| BlackRock, Inc. | $9.281.482 | 366.857 | 0,28% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $9.020.310 | 356.534 | 0,27% | Azioni |
| AMERIPRISE FINANCIAL INC | $8.039.177 | 317.754 | 0,24% | Azioni |
| PRUDENTIAL FINANCIAL INC | $7.985.313 | 315.625 | 0,24% | Azioni |
| Alyeska Investment Group, L.P. | $7.850.261 | 310.287 | 0,24% | Azioni |
| RHUMBLINE ADVISERS | $7.663.389 | 302.902 | 0,23% | Azioni |
| Schonfeld Strategic Advisors LLC | $7.189.171 | 284.157 | 0,22% | Azioni |
| Edgestream Partners, L.P. | $7.167.515 | 283.301 | 0,22% | Azioni |
| Logos Global Management LP | $6.325.000 | 250.000 | 0,19% | Azioni |
| LAZARD ASSET MANAGEMENT LLC | $6.263.496 | 247.569 | 0,19% | Azioni |
| FMR LLC | $6.052.317 | 239.222 | 0,18% | Azioni |
| Swiss National Bank | $5.841.871 | 230.904 | 0,18% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $5.432.213 | 214.712 | 0,16% | Azioni |
| ALPS ADVISORS INC | $4.985.340 | 197.049 | 0,15% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $4.926.239 | 194.713 | 0,15% | Azioni |
| Legal & General Group Plc | $4.918.245 | 194.397 | 0,15% | Azioni |
| FIRST TRUST ADVISORS LP | $4.664.965 | 184.386 | 0,14% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $4.364.807 | 172.522 | 0,13% | Azioni |
| Birchview Capital, LP | $4.326.300 | 171.000 | 0,13% | Azioni |
| MARTINGALE ASSET MANAGEMENT L P | $4.247.693 | 167.893 | 0,13% | Azioni |
| Tetragon Partners GP Ltd | $4.247.238 | 167.875 | 0,13% | Azioni |
| GREAT LAKES ADVISORS, LLC | $3.822.526 | 151.088 | 0,12% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $3.635.306 | 143.688 | 0,11% | Azioni |
| STEMPOINT CAPITAL LP | $3.622.125 | 143.167 | 0,11% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $3.585.329 | 161.066 | 0,11% | Azioni |
| Squarepoint Ops LLC | $3.542.329 | 140.013 | 0,11% | Azioni |
| ORBIMED ADVISORS LLC | $3.466.100 | 137.000 | 0,10% | Azioni |
| Erste Asset Management GmbH | $3.369.240 | 133.700 | 0,10% | Azioni |
| Emerald Investment Advisers, LLC | $3.333.326 | 131.752 | 0,10% | Azioni |
| Caption Management, LLC | $3.289.000 | 130.000 | 0,10% | Opzione Put |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.130.217 | 123.724 | 0,09% | Azioni |
| WELLS FARGO & COMPANY/MN | $3.084.475 | 121.916 | 0,09% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3.077.311 | 138.244 | 0,09% | Azioni |
| Longaeva Partners L.P. | $2.968.145 | 117.318 | 0,09% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.948.791 | 116.553 | 0,09% | Azioni |
| Trexquant Investment LP | $2.935.357 | 116.022 | 0,09% | Azioni |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2.909.778 | 115.011 | 0,09% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $2.868.477 | 113.289 | 0,09% | Azioni |
| Rafferty Asset Management, LLC | $2.789.426 | 110.254 | 0,08% | Azioni |
| Nan Fung Group Holdings Ltd | $2.605.495 | 102.984 | 0,08% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $2.406.232 | 95.108 | 0,07% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.344.000 | 92.648 | 0,07% | Azioni |
| ROYCE & ASSOCIATES LP | $2.324.691 | 91.885 | 0,07% | Azioni |
| HOHIMER WEALTH MANAGEMENT, LLC | $2.322.540 | 91.800 | 0,07% | Azioni |
| Point72 Europe (London) LLP | $2.305.047 | 108.015 | 0,07% | Azioni |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2.134.076 | 79.898 | 0,06% | Azioni |
| Campbell & CO Investment Adviser LLC | $2.108.527 | 83.341 | 0,06% | Azioni |
| Verdad Advisers, LP | $2.090.514 | 82.629 | 0,06% | Azioni |
| VOYA INVESTMENT MANAGEMENT LLC | $2.072.576 | 81.920 | 0,06% | Azioni |
| CITADEL ADVISORS LLC | $2.049.300 | 81.000 | 0,06% | Opzione Call |
| GUGGENHEIM CAPITAL LLC | $1.979.776 | 78.252 | 0,06% | Azioni |
| WESBANCO BANK INC | $1.978.460 | 78.200 | 0,06% | Azioni |
| Phocas Financial Corp. | $1.954.299 | 77.245 | 0,06% | Azioni |
| MetLife Investment Management, LLC | $1.899.043 | 75.061 | 0,06% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.850.493 | 73.142 | 0,06% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.788.331 | 70.685 | 0,05% | Azioni |
| Freestone Grove Partners LP | $1.755.643 | 69.393 | 0,05% | Azioni |
| CenterBook Partners LP | $1.743.878 | 68.928 | 0,05% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $1.722.930 | 68.100 | 0,05% | Azioni |
Insider aziendali 37 insider · 19 dirigenti · 19 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Stephen Davis | CEO | 06 Gennaio 2024 M | 96.521 | 0 | 0 | $0 |
| Uli Hacksell | CEO | 25 Marzo 2011 A | 69.916 | 0 | 0 | $0 |
| Elena Ridloff | EVP and CFO | 29 Aprile 2021 M | 10.553 | 0 | 0 | $0 |
| Todd S. Young | EVP AND CFO | 15 Ottobre 2018 A | — | 0 | 0 | $0 |
| Thomas H Aasen | Exec. VP, CFO & CBO | 25 Marzo 2011 A | 13.899 | 0 | 0 | $0 |
| Srdjan R. Stankovic | President | 21 Novembre 2022 M | 61.234 | 0 | 0 | $0 |
| Mark R Brann | President & CSO | 16 Giugno 2006 S | 317.756 | 0 | 0 | $0 |
| Brendan Teehan | EVP, COO, Head of Commercial | 06 Gennaio 2024 M | 30.949 | 0 | 0 | $0 |
| Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | 29 Luglio 2026 M | 18.994 | 0 | 2 | $-432.662 |
| James Kihara | PRINCIPAL ACCOUNTING OFFICER | 26 Giugno 2026 S | 13.088 | 0 | 2 | $-412.253 |
| Austin D. Kim | EVP,General Counsel, Secretary | 06 Gennaio 2024 M | 46.901 | 0 | 0 | $0 |
| Douglas J Williamson | Executive VP, Research & Dev | 10 Febbraio 2023 A | — | 0 | 0 | $0 |
| Michael J. Yang | EVP and CCO | 06 Gennaio 2021 M | 8.059 | 0 | 0 | $0 |
| Eric Alejandro Miller | Controller & PAO | 15 Ottobre 2019 M | 270 | 0 | 0 | $0 |
| Glenn Baity | VP, GC & Sec. | 25 Marzo 2011 A | — | 0 | 0 | $0 |
| Roger Mills | Executive VP, Development | 25 Marzo 2011 A | — | 0 | 0 | $0 |
| Bo-Ragnar Tolf | VP/Mg. Dir. ACADIA Pharma AB | 08 Luglio 2009 M | 20.000 | 0 | 0 | $0 |
| Brian Lundstrom | Sr. VP, Bus. Development | 07 Marzo 2008 A | 0 | 0 | 0 | $0 |
| Robert E Davis | Exec. VP, Drug Discovery | 11 Marzo 2005 A | — | 0 | 0 | $0 |
| Adora Ndu | Direttore | 29 Maggio 2026 A | 32.908 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | Direttore | 29 Maggio 2026 A | 33.489 | 0 | 0 | $0 |
| Jonathan Poole | Direttore | 29 Maggio 2026 A | 2.010 | 0 | 0 | $0 |
| James M Daly | Direttore | 29 Maggio 2026 A | 12.148 | 0 | 0 | $0 |
| Laura Brege | Direttore | 29 Maggio 2026 A | 23.202 | 0 | 0 | $0 |
| Edmund Harrigan | Direttore | 29 Maggio 2026 A | 43.148 | 0 | 0 | $0 |
| Daniel B Soland | Direttore | 01 Giugno 2023 A | 28.002 | 0 | 0 | $0 |
| Torsten Rasmussen | Direttore | 11 Giugno 2010 A | 4.000 | 0 | 0 | $0 |
| Leslie L Iversen | Direttore | 11 Giugno 2010 A | 9.000 | 0 | 0 | $0 |
| Mary Ann Gray | Direttore | 11 Giugno 2010 A | — | 0 | 0 | $0 |
| Michael T Borer | Direttore | 11 Giugno 2010 A | — | 0 | 0 | $0 |
| Lester J Ph D Kaplan | Direttore | 11 Giugno 2010 A | 4.000 | 0 | 0 | $0 |
| Gordon M Binder | Direttore | 12 Giugno 2009 A | 14.364 | 0 | 0 | $0 |
| Alan G Walton | Direttore | 12 Giugno 2009 A | 25.979 | 0 | 0 | $0 |
| Martien Van Osch | Direttore | 10 Giugno 2005 A | 1.168.892 | 0 | 0 | $0 |
| GORDON CARL L | Direttore | 20 Aprile 2005 A | 774.006 | 0 | 0 | $0 |
| Mark C. Schneyer | — | 06 Agosto 2026 M | 67.828 | 0 | 3 | $-587.248 |
| John Joseph Kaiser | — | 20 Ottobre 2008 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 6 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×14 depositi | 26 Febbraio 2026 | 25,40% | Modifica | — | SEC |
| Baker Bros. Advisors, LLC, Felix J. Baker, Julian C. Baker ×4 depositi | 06 Giugno 2013 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 02 Maggio 2005 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 02 Maggio 2005 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 02 Maggio 2005 | — | Deposito iniziale | — | SEC |
| Oxford Bioscience Partners IV L.P., mRNA Fund II L.P., OBP Management IV L.P., Jeffrey T. Barnes, Mark P. Carthy, Jonathan J. Fleming, Michael E. Lytton, Alan G. Walton | 29 Aprile 2005 | — | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 77 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IBRN · iShares Trust | 4,89% | 13.265 SH | 08 Agosto 2026 | Giornaliero |
| PBE · Invesco Exchange-Traded Fund Trust | 3,29% | 407.914 SH | 08 Agosto 2026 | Giornaliero |
| SBIO · ALPS ETF Trust | 2,35% | 175.740 NS | 31 Maggio 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,87% | 109.972 SH | 08 Agosto 2026 | Giornaliero |
| BBP · ETFis Series Trust I | 1,32% | 34.855 NS | 30 Aprile 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1,25% | 59.514 SH | 08 Agosto 2026 | Giornaliero |
| LABU · Direxion Shares ETF Trust | 0,85% | 195.542 NS | 30 Aprile 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,56% | 13.607 NS | 30 Aprile 2026 | N-PORT |
| IJT · iShares Trust | 0,40% | 1.176.933 SH | 08 Agosto 2026 | Giornaliero |
| OASC · Unified Series Trust | 0,39% | 15.269 NS | 31 Maggio 2026 | N-PORT |
| IBB · iShares Trust | 0,37% | 1.239.145 SH | 08 Agosto 2026 | Giornaliero |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,35% | 150.827 SH | 08 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,34% | 9.317 SH | 08 Agosto 2026 | Giornaliero |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,27% | 61.606 NS | 30 Aprile 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,24% | 24.003 NS | 31 Maggio 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,23% | 20.369 SH | 08 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,23% | 1.166.817 SH | 08 Agosto 2026 | Giornaliero |
| XJR · iShares Trust | 0,23% | 14.974 SH | 08 Agosto 2026 | Giornaliero |
| GSSC · Goldman Sachs ETF Trust | 0,20% | 89.945 NS | 31 Maggio 2026 | N-PORT |
| IJR · iShares Trust | 0,20% | 7.728.433 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,19% | 137.860 SH | 08 Agosto 2026 | Giornaliero |
| BIB · ProShares Trust | 0,19% | 6.303 NS | 31 Maggio 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,17% | 443.221 SH | 08 Agosto 2026 | Giornaliero |
| BKSE · BNY Mellon ETF Trust | 0,17% | 6.035 NS | 30 Aprile 2026 | N-PORT |
| SMMV · iShares Trust | 0,17% | 17.063 SH | 08 Agosto 2026 | Giornaliero |
| SMLF · iShares Trust | 0,15% | 219.745 SH | 08 Agosto 2026 | Giornaliero |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 47.683 NS | 30 Aprile 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,14% | 137.072 SH | 08 Agosto 2026 | Giornaliero |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 81.552 NS | 30 Aprile 2026 | N-PORT |
| SAA · ProShares Trust | 0,12% | 1.498 NS | 31 Maggio 2026 | N-PORT |
| IWM · iShares Trust | 0,12% | 3.281.125 SH | 08 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | 0,11% | 39.884 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 741.237 SH | 08 Agosto 2026 | Giornaliero |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,09% | 66.331 SH | 08 Agosto 2026 | Giornaliero |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1.699.377 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,09% | 115.210 NS | 31 Maggio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,08% | 526.641 NS | 30 Aprile 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 16.957 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,07% | 5.921 NS | 31 Maggio 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,06% | 599.784 NS | 31 Maggio 2026 | N-PORT |
| ISCB · iShares Trust | 0,06% | 5.636 SH | 08 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 54.956 NS | 30 Aprile 2026 | N-PORT |
| IEUS · iShares Trust | 0,04% | 7.411 SH | 08 Agosto 2026 | Giornaliero |
| SMDX · Tidal Trust III | 0,04% | 2.306 NS | 30 Aprile 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 4.033 SH | 08 Agosto 2026 | Giornaliero |
| UWM · ProShares Trust | 0,04% | 4.631 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.457.036 SH | 08 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,04% | 2.944.095 SH | 08 Agosto 2026 | Giornaliero |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,04% | 14.209 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,04% | 346.329 SH | 08 Agosto 2026 | Giornaliero |